{"transactions":[{"id":801768,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO and CFO"}}],"security":"Common Stock","published_at":"2026-04-23T21:00:02.000Z","date":"2026-04-21","kind":"grant","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents a restricted stock grant (\"RSG\"). The shares represented by the RSG will vest and become exercisable as follows: 7,000 shares shall vest on the date of grant and one-third of the remaining (93,000) shares shall vest on each of the first, second and third anniversaries of April 21, 2026."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001683168-26-003163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316826003163/ownership.xml","form_type":"4"}},{"id":950295,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-01-05T22:00:07.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":2.17,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-26-000104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316826000104/ownership.xml","form_type":"4"}},{"id":950293,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70265,"kind":"person","name":"Borisenko Grigory G.","position":1,"cik":"0001788924","reported_name":"Borisenko Grigory G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-01-05T22:00:02.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":2.17,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-26-000101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316826000101/ownership.xml","form_type":"4"}},{"id":951528,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-01-05T17:00:05.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":2.17,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-26-000103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316826000103/ownership.xml","form_type":"4"}},{"id":951093,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-01-05T17:00:04.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":2.17,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-26-000102","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316826000102/ownership.xml","form_type":"4"}},{"id":1331978,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70265,"kind":"person","name":"Borisenko Grigory G.","position":1,"cik":"0001788924","reported_name":"Borisenko Grigory G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-13T22:00:08.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.24,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-24-008719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824008719/ownership.xml","form_type":"4"}},{"id":1331977,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-13T22:00:05.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.24,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-24-008717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824008717/ownership.xml","form_type":"4"}},{"id":1332227,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-13T17:00:09.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.24,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-24-008720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316824008720/ownership.xml","form_type":"4"}},{"id":1332354,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-13T17:00:06.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.24,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-24-008718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316824008718/ownership.xml","form_type":"4"}},{"id":1471909,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO and CFO"}}],"security":"Stock Options","published_at":"2024-06-21T21:00:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-fourth of the shares shall vest on the date of grant and one-fourth of the shares shall vest on each of the first, second and third anniversaries of June 18, 2024 ending on June 18, 2027."}],"balance_after":20000,"derivative":{"exercise_price":3.99,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-24-004421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316824004421/ownership.xml","form_type":"4"}},{"id":1707393,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":58668,"kind":"person","name":"Mizrahy Moshe","position":1,"cik":"0001803068","reported_name":"Mizrahy Moshe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-18T22:18:54.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1803068/000168316823008917/ownership.xml","form_type":"4"}},{"id":1712351,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2023-12-13T22:30:08.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026."}],"balance_after":10000,"derivative":{"exercise_price":3.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-23-008826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316823008826/ownership.xml","form_type":"4"}},{"id":1712206,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sciencific Officer"}}],"security":"Stock Options","published_at":"2023-12-13T17:30:10.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026."}],"balance_after":10000,"derivative":{"exercise_price":3.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-23-008825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316823008825/ownership.xml","form_type":"4"}},{"id":1712286,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-12-13T17:30:08.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026."}],"balance_after":20000,"derivative":{"exercise_price":3.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-23-008824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000168316823008824/ownership.xml","form_type":"4"}},{"id":1717542,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70265,"kind":"person","name":"Borisenko Grigory G.","position":1,"cik":"0001788924","reported_name":"Borisenko Grigory G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T22:30:21.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316823008736/ownership.xml","form_type":"4"}},{"id":1717541,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T22:30:15.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316823008739/ownership.xml","form_type":"4"}},{"id":1717540,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T22:30:11.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008738","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316823008738/ownership.xml","form_type":"4"}},{"id":1717704,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T22:30:08.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008735","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316823008735/ownership.xml","form_type":"4"}},{"id":1717754,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T17:30:23.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008740","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316823008740/ownership.xml","form_type":"4"}},{"id":1717966,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T17:30:18.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008737","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316823008737/ownership.xml","form_type":"4"}},{"id":2090956,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T22:05:03.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008325/ownership.xml","form_type":"4"}},{"id":2091034,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T22:04:11.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316822008324/ownership.xml","form_type":"4"}},{"id":2090826,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T22:02:18.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008321/ownership.xml","form_type":"4"}},{"id":2090825,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70265,"kind":"person","name":"Borisenko Grigory G.","position":1,"cik":"0001788924","reported_name":"Borisenko Grigory G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T22:01:57.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008320","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008320/ownership.xml","form_type":"4"}},{"id":2091059,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T17:03:37.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008323","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316822008323/ownership.xml","form_type":"4"}},{"id":2091137,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T17:02:55.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316822008322/ownership.xml","form_type":"4"}},{"id":2316493,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2022-03-28T21:14:50.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-22-002002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316822002002/ownership.xml","form_type":"4"}},{"id":2316451,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2022-03-28T17:16:48.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025."}],"balance_after":100000,"derivative":{"exercise_price":1.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001683168-22-002000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000168316822002000/ownership.xml","form_type":"4"}},{"id":2316384,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sciencific Officer"}}],"security":"Stock Options","published_at":"2022-03-28T17:13:39.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-22-002001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316822002001/ownership.xml","form_type":"4"}},{"id":2478813,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-10T01:09:31.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006234","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316821006234/ownership.xml","form_type":"4"}},{"id":2478598,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-09T22:40:43.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316821006231/ownership.xml","form_type":"4"}},{"id":2478597,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-09T22:39:36.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316821006228/ownership.xml","form_type":"4"}},{"id":2478873,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-09T17:40:33.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316821006230/ownership.xml","form_type":"4"}},{"id":2478962,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-09T17:40:05.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006229","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316821006229/ownership.xml","form_type":"4"}},{"id":2776120,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-03-22T21:30:26.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024."}],"balance_after":50000,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-21-001019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316821001019/ownership.xml","form_type":"4"}},{"id":2776113,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-03-22T17:30:19.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024."}],"balance_after":100000,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001683168-21-001018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000168316821001018/ownership.xml","form_type":"4"}},{"id":2776045,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sciencific Officer"}}],"security":"Stock Options","published_at":"2021-03-22T17:30:17.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024."}],"balance_after":50000,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-21-001020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316821001020/ownership.xml","form_type":"4"}},{"id":2953054,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T22:05:49.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316820004207/ownership.xml","form_type":"4"}},{"id":2953253,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T22:04:47.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316820004206/ownership.xml","form_type":"4"}},{"id":2953053,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T22:00:57.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004203","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316820004203/ownership.xml","form_type":"4"}},{"id":2953311,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T17:03:29.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004205","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316820004205/ownership.xml","form_type":"4"}},{"id":2953512,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T17:01:56.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004204","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316820004204/ownership.xml","form_type":"4"}},{"id":3349602,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-12-06T23:42:01.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: 26,666 shares shall vest on the first anniversary of December 4, 2019 (\"Vesting Start Date\"); 26,667 shares shall vest on the second anniversary of the Vesting Start Date; and 26,667 shares shall vest on the third anniversary of the Vesting Start Date."}],"balance_after":80000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001683168-19-003923","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316819003923/ownership.xml","form_type":"4"}},{"id":3349663,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T23:39:35.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316819003921/ownership.xml","form_type":"4"}},{"id":3349369,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T23:25:29.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316819003911/ownership.xml","form_type":"4"}},{"id":3349433,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2019-12-06T18:37:34.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: 30,000 shares shall vest on the first anniversary of December 4, 2019 (\"Vesting Start Date\"); 30,000 shares shall vest on the second anniversary of the Vesting Start Date; and 30,000 shares shall vest on the third anniversary of the Vesting Start Date."}],"balance_after":90000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001683168-19-003919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316819003919/ownership.xml","form_type":"4"}},{"id":3349688,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T18:33:52.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000168316819003917/ownership.xml","form_type":"4"}},{"id":3349564,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2019-12-06T18:30:27.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: 76,666 shares shall vest on the first anniversary of December 4, 2019 (\"Vesting Start Date\"); 76,667 shares shall vest on the second anniversary of the Vesting Start Date; and 76,667 shares shall vest on the third anniversary of the Vesting Start Date."}],"balance_after":230000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001683168-19-003915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000168316819003915/ownership.xml","form_type":"4"}},{"id":3349829,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T18:28:06.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000168316819003913/ownership.xml","form_type":"4"}},{"id":3404214,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70266,"kind":"person","name":"VINOGRADOV ALEXEY ANDREEVICH","position":1,"cik":"0001784315","reported_name":"VINOGRADOV ALEXEY ANDREEVICH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-09-30T21:36:35.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.395,"expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316819003107/ownership.xml","form_type":"4"}},{"id":3404194,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70265,"kind":"person","name":"Borisenko Grigory G.","position":1,"cik":"0001788924","reported_name":"Borisenko Grigory G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-09-30T21:35:58.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.395,"expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316819003106/ownership.xml","form_type":"4"}},{"id":3457280,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":155891,"kind":"person","name":"Genkin Dmitry","position":1,"cik":"0001711592","reported_name":"Genkin Dmitry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-23T22:50:49.000Z","date":"2019-07-19","kind":"grant","acquired":true,"shares":93390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares acquired in connection the closing of the transaction contemplated by that certain Share Purchase agreement, dated March 1, 2019, with Hesperix SA, a Swiss corporation (\"Hesperix\"), the owners of Hesperix (each, a \"Seller\" and collectively, the \"Sellers\"), and Alexey Andreevich Vinogradov, as the representative of each Seller. The Reporting Person was a Seller in the transaction. On the closing date, the closing price of the Issuer's common stock was $4.85."}],"balance_after":93603,"source":{"system":"sec-edgar","filing":"0001683168-19-002304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316819002304/ownership.xml","form_type":"4"}},{"id":3680954,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":155891,"kind":"person","name":"Genkin Dmitry","position":1,"cik":"0001711592","reported_name":"Genkin Dmitry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-31T21:30:40.000Z","date":"2018-03-14","kind":"other","acquired":false,"shares":29452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 14, 2018, the Reporting Person transferred 29,452 shares to a third party as part of a settlement agreement dated October 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 14, 2018, the Reporting Person transferred 29,452 shares to a third party as part of a settlement agreement dated October 18, 2017."}],"balance_after":2549,"source":{"system":"sec-edgar","filing":"0001662252-19-000014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225219000014/ownership.xml","form_type":"4"}},{"id":3747231,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-30T22:24:59.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.05,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-18-000107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225218000107/ownership.xml","form_type":"4"}},{"id":3747473,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-30T22:23:11.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.05,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-18-000105","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225218000105/ownership.xml","form_type":"4"}},{"id":3747704,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-30T17:24:10.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.05,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-18-000106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000166225218000106/ownership.xml","form_type":"4"}},{"id":3747547,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-30T17:22:10.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.05,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-18-000104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000166225218000104/ownership.xml","form_type":"4"}},{"id":4158408,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":70323,"kind":"person","name":"Dastoor Firdaus J.","position":1,"cik":"0001690576","reported_name":"Dastoor Firdaus J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-11-17T17:39:10.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 15, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on November 15, 2017 of $2.18. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.18,"expiration_date":"2027-11-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-17-000232","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690576/000166225217000232/form4.xml","form_type":"4"}},{"id":4158037,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-11-17T17:34:10.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 15, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on November 15, 2017 of $2.18. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.18,"expiration_date":"2027-11-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-17-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000166225217000230/form4.xml","form_type":"4"}},{"id":4178406,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options","published_at":"2017-10-30T21:09:20.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option will vest and become exercisable as follows: 41,666 shares shall vest on the first anniversary of October 26, 2017 (the \"Vesting Start Date\"); 41,667 shares shall vest on the second anniversary of the Vesting Start Date; 41,667 shares shall vest on the third anniversary of the Vesting Start Date; 100,000 shares shall vest upon the achievement of key clinical milestones for XBIO-101; and 25,000 shares shall vest upon the achievement of key development milestones related to PSA. The Reporting Owner may not exercise any of the shares under the option if and until the Issuer receives shareholder approval of an increase in the number of shares of common stock authorized under the Company's equity incentive plan on or prior to October 11, 2018."}],"balance_after":250000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001662252-17-000220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000166225217000220/form4.xml","form_type":"4"}},{"id":4178405,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-10-30T21:09:20.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents the grant of a restricted stock unit (\"RSU\") award. Each RSU represents the right to receive one share of the Issuer's common stock at vesting. The shares underlying the RSUs will vest and become exercisable as follows: one-third on the first anniversary of October 26, 2017 (the \"Vesting Start Date\"); one-third on the second anniversary of the Vesting Start Date; and one-third on the third anniversary of the Vesting Start Date."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001662252-17-000220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000166225217000220/form4.xml","form_type":"4"}},{"id":4186546,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.95,"exercise_date":"2018-10-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186545,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":18750,"derivative":{"exercise_price":2.95,"exercise_date":"2018-07-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186544,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":12500,"derivative":{"exercise_price":2.95,"exercise_date":"2018-04-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186543,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":6250,"derivative":{"exercise_price":2.95,"exercise_date":"2018-01-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186413,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.95,"exercise_date":"2018-10-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4186412,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":18750,"derivative":{"exercise_price":2.95,"exercise_date":"2018-07-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4186411,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":12500,"derivative":{"exercise_price":2.95,"exercise_date":"2018-04-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4186410,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":6250,"derivative":{"exercise_price":2.95,"exercise_date":"2018-01-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4281301,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-15T20:57:29.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that she beneficially owned an aggregate of 61,416 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":40000,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-17-000119","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225217000119/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281300,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-15T20:57:29.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that she beneficially owned an aggregate of 61,416 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":30000,"derivative":{"exercise_price":3.5,"exercise_date":"2017-09-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-17-000119","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225217000119/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281299,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-15T20:57:29.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that she beneficially owned an aggregate of 61,416 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":20000,"derivative":{"exercise_price":3.5,"exercise_date":"2017-06-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-17-000119","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225217000119/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281298,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-15T20:57:29.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that she beneficially owned an aggregate of 61,416 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":10000,"derivative":{"exercise_price":3.5,"exercise_date":"2017-03-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-17-000119","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225217000119/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281080,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2017-06-15T17:14:10.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that he beneficially owned an aggregate of 433,786 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":250000,"derivative":{"exercise_price":3.5,"exercise_date":"2019-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-17-000123","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225217000123/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281079,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2017-06-15T17:14:10.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that he beneficially owned an aggregate of 433,786 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":166667,"derivative":{"exercise_price":3.5,"exercise_date":"2018-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-17-000123","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225217000123/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281078,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2017-06-15T17:14:10.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that he beneficially owned an aggregate of 433,786 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":83333,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001662252-17-000123","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225217000123/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4360580,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-04T12:08:52.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest and become exercisable over three years, with one-third of the underlying shares vesting on each of April 3, 2018, April 3, 2019 and April 3, 2020, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":175000,"derivative":{"exercise_price":4.57,"expiration_date":"2027-04-03","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-17-024356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000120919117024356/doc4.xml","form_type":"4"}},{"id":4512558,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.49,"exercise_date":"2017-11-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512557,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":18750,"derivative":{"exercise_price":3.49,"exercise_date":"2017-08-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512556,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":12500,"derivative":{"exercise_price":3.49,"exercise_date":"2017-05-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512555,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":6250,"derivative":{"exercise_price":3.49,"exercise_date":"2017-02-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512681,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T18:58:51.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."}],"balance_after":61416,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-16-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225216000299/form4.xml","form_type":"4"}},{"id":4512680,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T18:58:51.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."}],"balance_after":51416,"derivative":{"exercise_price":3.5,"exercise_date":"2017-09-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-16-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225216000299/form4.xml","form_type":"4"}},{"id":4512679,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T18:58:51.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."}],"balance_after":41416,"derivative":{"exercise_price":3.5,"exercise_date":"2017-06-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-16-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225216000299/form4.xml","form_type":"4"}},{"id":4512678,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":39423,"kind":"person","name":"DEPTULA-HICKS DARLENE M","position":1,"cik":"0001089409","reported_name":"DEPTULA-HICKS DARLENE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T18:58:51.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months."}],"balance_after":31416,"derivative":{"exercise_price":3.5,"exercise_date":"2017-03-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001662252-16-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089409/000166225216000299/form4.xml","form_type":"4"}},{"id":4512554,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2016-12-23T14:20:40.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."}],"balance_after":443786,"derivative":{"exercise_price":3.5,"exercise_date":"2019-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-16-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225216000305/form4.xml","form_type":"4"}},{"id":4512553,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2016-12-23T14:20:40.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."}],"balance_after":360453,"derivative":{"exercise_price":3.5,"exercise_date":"2018-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-16-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225216000305/form4.xml","form_type":"4"}},{"id":4512552,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2016-12-23T14:20:40.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."}],"balance_after":277120,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001662252-16-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225216000305/form4.xml","form_type":"4"}},{"id":4512411,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T14:09:47.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":21970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 21,970 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50."}],"balance_after":25000,"derivative":{"exercise_price":3.5,"exercise_date":"2016-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":21970},"source":{"system":"sec-edgar","filing":"0001662252-16-000303","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000166225216000303/form4.xml","form_type":"4"}},{"id":4512410,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":69439,"kind":"person","name":"Kornberg Roger D.","position":1,"cik":"0001444532","reported_name":"Kornberg Roger D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T14:09:47.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":3030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The grant had been approved and was part of an agreement (but not issued) on the date of the Reporting Owner began service as a director of the Issuer.  Under the agreement and grant, the Reporting Owner has the right to purchase 3,030 shares of common stock of the Issuer under the Plan at an exercise price based on the adjusted price of the stock on the date of his appointment to the board."}],"balance_after":3030,"derivative":{"exercise_price":10.23,"exercise_date":"2016-12-20","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":3030},"source":{"system":"sec-edgar","filing":"0001662252-16-000303","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444532/000166225216000303/form4.xml","form_type":"4"}},{"id":4531116,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock Options","published_at":"2016-12-06T16:07:18.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":75100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":230000,"derivative":{"exercise_price":3.4,"exercise_date":"2019-12-02","expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":75100},"source":{"system":"sec-edgar","filing":"0001662252-16-000276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000166225216000276/form4.xml","form_type":"4"}},{"id":4531115,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock Options","published_at":"2016-12-06T16:07:18.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":75100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":154900,"derivative":{"exercise_price":3.4,"exercise_date":"2018-12-02","expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":75100},"source":{"system":"sec-edgar","filing":"0001662252-16-000276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000166225216000276/form4.xml","form_type":"4"}},{"id":4531114,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock Options","published_at":"2016-12-06T16:07:18.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":75100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79800,"derivative":{"exercise_price":3.4,"exercise_date":"2017-12-02","expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":75100},"source":{"system":"sec-edgar","filing":"0001662252-16-000276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000166225216000276/form4.xml","form_type":"4"}},{"id":4531113,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96177,"kind":"person","name":"EISENBERG JEFFREY F","position":1,"cik":"0001224096","reported_name":"EISENBERG JEFFREY F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock Options","published_at":"2016-12-06T16:07:18.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 2, 2016 the Issuer entered into an Employment Agreement with Mr. Eisenberg. Under the terms of the Employment Agreement, Mr. Eisenberg has the right to purchase 230,000 shares of common stock of the Issuer (the \"Option\") under the Issuer's Equity Incentive Plan, effective January 23, 2014 (the \"Plan\") at an exercise price equal to the fair market value of the Company's common stock on the grant date. 4,700 shares were granted pursuant to the Option were deemed vested immediately. The Options expire December 1, 2026."}],"balance_after":4700,"derivative":{"exercise_price":3.4,"exercise_date":"2016-12-02","expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":4700},"source":{"system":"sec-edgar","filing":"0001662252-16-000276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224096/000166225216000276/form4.xml","form_type":"4"}}]}